To study the improvement in hearing by using combination therapy ( oral steroids and platelet rich plasma) in sudden hearing loss
Not Applicable
- Conditions
- Health Condition 1: H838- Other specified diseases of innerear
- Registration Number
- CTRI/2020/09/027804
- Lead Sponsor
- ttrakhand state council for science and technologyUCOST
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Unexplained sudden sensorineural hearing loss, which is defined as a
sensorineural hearing loss of at least 30 dB at 3 contiguous frequencies over a period
of <_3 days; Unilateral/bilateral
2. Normal tympanic membrane on otoendoscopy
3. No history of ear disease in the affected ear
4.Age 18-50 years
Exclusion Criteria
1.Patients with conductive HL, mixed HL or other causes of sensori-neural hearing loss.
2.Patients with perforated ear drum
3.Age <18 years and > 50 yrs
4. Operated ear
5. Individuals with a previous history of ear discharge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hearing gain reporting as per American Association of Otorhinolaryngology-Head Neck Surgery guidelines with PTA at 0.5-,1-,2- and 3KHz and recovery outcome using modified Siegleâ??s criteria.Timepoint: follow up at 2nd and 4th week
- Secondary Outcome Measures
Name Time Method Improvement in speech discrimination score (SDS) Reduction in tinnitus perception in both groups based on Tinnitus Functional Index and Tinnitogram.Timepoint: follow up at 2nd and 4th week